BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November

Day

• 1
• 2
• 3
• 5
• 6
• 7
• 8
• 9
• 10
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30
• 31

• Press Releases

  Merck Announces KEYTRUDA® (pembrolizumab) Plus WELIREG® (belzutifan) Met Primary Endpoint of Disease-Free Survival (DFS) in Certain Patients With Clear Cell Renal Cell Carcinoma (RCC) Following Nephrectomy

  October 28, 2025

   · 

  19 min read
• Press Releases

  Merck and Eisai Announce WELIREG® (belzutifan) Plus LENVIMA® (lenvatinib) Met Primary Endpoint of Progression-Free Survival (PFS) in Certain Previously Treated Patients With Advanced Renal Cell Carcinoma

  October 28, 2025

   · 

  19 min read
• Press Releases

  GeneDx Reports Third Quarter 2025 Financial Results and Business Highlights

  October 28, 2025

   · 

  17 min read
• Press Releases

  Compass Pathways to Announce Third Quarter Financial Results on November 4, 2025

  October 28, 2025

   · 

  1 min read
• Press Releases

  ONL Therapeutics Announces Randomization of First Patient in Global Phase 2 GALAXY Trial of Xelafaslatide (ONL1204) in Patients with Geographic Atrophy (GA) Associated with Dry AMD

  October 28, 2025

   · 

  4 min read
• Press Releases

  Lifecore and PolyPeptide Announce Collaboration Intended to Offer End-to-End Peptide Manufacturing Solution for U.S. Market

  October 28, 2025

   · 

  5 min read
• Press Releases

  Invivyd to Host Webcast on the REVOLUTION Clinical Program for VYD2311, a Vaccine-Alternative Antibody to Prevent COVID

  October 28, 2025

   · 

  6 min read
• Press Releases

  Causeway Therapeutics Debuts Positive Data from Phase 2 Clinical Trial of TenoMiR® for Lateral Epicondylitis

  October 28, 2025

   · 

  4 min read
• Press Releases

  Kymera Therapeutics to Report Third Quarter 2025 Financial Results on November 4, 2025

  October 28, 2025

   · 

  1 min read
• Press Releases

  Entrada Therapeutics to Present at Upcoming Investor Conferences - October 28, 2025

  October 28, 2025

   · 

  1 min read